2022年5期
刊物介紹
本刊主要是及時報道我國在腫瘤防治研究領域包括癌癥基礎理論研究和癌癥預防、臨床治療研究方面的新進展、新成果，內容涉及腫瘤病因學與滸病學，實驗腫瘤學、腫瘤細胞分子生物學，腫瘤病理學以及腫瘤影像診斷、腫瘤外科治療、化學治療、放射治療、介入治療、生物治療和中西醫(yī)結合治療腫瘤等各分支學科，旨在促進國內外學術交流，提高我國癌癥研究與癌癥治療水平。
Chinese Journal of Cancer Research
NHCPRC Guidelines
Editorial
- Comments on National guidelines for diagnosis and treatment of thyroid cancer 2022 in China (English version)
- Comments on National guidelines for diagnosis and treatment of breast cancer 2022 in China (English version)
- Comments on National guidelines for diagnosis and treatment of gastric cancer 2022 in China (English version)
- Comments on National guidelines for diagnosis and treatment of prostate cancer 2022 in China (English version)
- Comments on National guidelines for diagnosis and treatment of cervical cancer 2022 in China (English version)
Review Article
Original Article
- Colorectal cancer burden,trends and risk factors in China:A review and comparison with the United States
- Evaluation of triage strategies for high-risk human papillomavirus-positive women in cervical cancer screening: A multicenter randomized controlled trial in different resource settings in China
- Correlation between imaging features on computed tomography and combined positive score of PD-L1 expression in patients with gastric cancer
- Characteristics of lymph node stations/basins metastasis and construction and validation of a preoperative combination prediction model that accurately excludes lymph node metastasis in early gastric cancer